<SEC-DOCUMENT>0001654954-19-011702-index.html : 20191015
<SEC-HEADER>0001654954-19-011702.hdr.sgml : 20191015
<ACCEPTANCE-DATETIME>20191015065237
ACCESSION NUMBER:		0001654954-19-011702
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20191015
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20191015
DATE AS OF CHANGE:		20191015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEL SCI CORP
		CENTRAL INDEX KEY:			0000725363
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				840916344
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11889
		FILM NUMBER:		191149058

	BUSINESS ADDRESS:	
		STREET 1:		8229 BOONE BLVD .
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182
		BUSINESS PHONE:		7035069460

	MAIL ADDRESS:	
		STREET 1:		8229 BOONE BLVD.
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERLEUKIN 2 INC
		DATE OF NAME CHANGE:	19880317
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cvm_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: cvm_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.C
<SEQUENCE>2
<FILENAME>cvm_ex3c.htm
<DESCRIPTION>AMENDED AND RESTATED ARTICLES OF INCORPORATION
<TEXT>
Document 2 - file: cvm_ex3c.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.D
<SEQUENCE>3
<FILENAME>cvm_ex3d.htm
<DESCRIPTION>BYLAWS
<TEXT>
Document 3 - file: cvm_ex3d.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>4
<FILENAME>cvm_ex107.htm
<DESCRIPTION>2019 NON-QUALIFIED STOCK OPTION PLAN
<TEXT>
Document 4 - file: cvm_ex107.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>5
<FILENAME>cvm_ex108.htm
<DESCRIPTION>2019 STOCK COMPENSATION PLAN
<TEXT>
Document 5 - file: cvm_ex108.htm

</DOCUMENT>
</SEC-DOCUMENT>